Home
News
Insight
Timeline
Video report
Editorial charter
Editors
Links
Contact
Home
> Insight
> PCSK9 inhibitors and hypercholesterolemia
Pr Christopher Cannon: PCSK9 inhibitors and hypercholesterolemia
Download Podcasts
Loading . . .
PCSK9 inhibitors and Hypercholesterolemia
...
00:00
Send to a colleague
Create an account
I forgot my password
Remember me
Speciality
Administrative & Hospital
Allergy and Immunology
Anatomopathology
Anesthesiology
Biology
Cardiology
Cellular Therapy
Clinical Pharmacology
Dermatology
Emergency and critical care medicine
Endocrinology and diabetology
Family medicine / General practice
Gastroenterology
Geriatrics
Hematology
Hepatology
Infectiology
Intensive care
Internal medecine
Legal medicine
Medical Student
Neonatology
Nephrology
Neurology
Nuclear Medicine
Nutrition
Obstetrics and gynecology
Occupational and environmental medicine
Oncology
Ophthalmology
Other
Otolaryngology
Parasitology
Pediatrics
Pharmacist
Phlebology
Physical medicine and rehabilitation
Pneumology
Press
Psychiatry
Radiology
Radiotherapy
Rheumatology
School Medicine
Sexology
Sports medecine
Stomatology
Surgery
Thermal/Spa Medicine
Toxicology
Urology
Vascular medicine
Virology
Previous editions
Sunday 1 October 2017
Saturday 10 June 2017
Friday 9 June 2017
Tuesday 31 May 2016
Sunday 17 January 2016
Partnership
Best of Science in Nutrition 2013: Yogurt for a healthier diet (EB & IUNS 2013)
Url
with
Danone Institute International
